Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 33, 2022 - Issue 5
Submit an article Journal homepage
128
Views
2
CrossRef citations to date
0
Altmetric
Letters to the Editor

Incidence and prognosis of COVID-19 in patients with atopic diseases on dupilumab: a multicentre retrospective cohort study

Brian D. Rankina Cumming School of Medicine, University of Calgary, Calgary, Alberta, CanadaORCID Iconhttps://orcid.org/0000-0001-9283-6312
ORCID Icon,
Jorge-Ryan Georgakopoulosb Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada
,
Muskaan Sachdevaw Faculty of Medicine, University of Toronto, Toronto, Ontario, CanadaORCID Iconhttps://orcid.org/0000-0002-2252-5663
ORCID Icon,
Asfandyar Muftib Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada
,
Alim R. Devanic Dermatology Research Institute, Calgary, Alberta, Canada;d Skin Health & Wellness Centre, Calgary, Alberta, Canada;e Probity Medical Research, Calgary, Alberta, Canada
,
Melinda J. Gooderhamf Queen's University, Kingston, Ontario, Canada;g SKiN Centre for Dermatology, Peterborough, Ontario, Canada;h Probity Medical Research, Peterborough, Ontario, CanadaORCID Iconhttps://orcid.org/0000-0001-8926-0113
ORCID Icon,
Chih-Ho Hongi Department of Dermatology and Skin Science, University of British Columbia, Vancouver, British Columbia, Canada;j Dr. Chih-Ho Hong Medical Inc, Surrey, British Columbia,CanadaORCID Iconhttps://orcid.org/0000-0001-9963-8319
ORCID Icon,
Vipul Jaink Division of Clinical Immunology and Allergy, McMaster University, Hamilton, Ontario, Canada;l Niagara Region Medical, Niagara Falls, Ontario, Canada;m Allergy Research Canada Inc, Niagara Falls, Ontario, Canada;n Probity Medical Research, Niagara Falls, Ontario, Canada
,
Perla Lansangb Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada;o Division of Dermatology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada;p Section of Paediatric Dermatology, Department of Paediatric Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada
,
Ronald Vendert Department of Dermatology, McMaster University, Hamilton, Ontario, Canada;u Dermatrials Research Inc. & Venderm Innovations in Psoriasis, Hamilton, Ontario, CanadaORCID Iconhttps://orcid.org/0000-0002-2624-2724
ORCID Icon,
Jensen Yeungb Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada;o Division of Dermatology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada;p Section of Paediatric Dermatology, Department of Paediatric Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada;q Probity Medical Research Inc, Waterloo, Ontario, CanadaORCID Iconhttps://orcid.org/0000-0002-7318-5515
ORCID Icon &
Vimal H. Prajapatic Dermatology Research Institute, Calgary, Alberta, Canada;d Skin Health & Wellness Centre, Calgary, Alberta, Canada;e Probity Medical Research, Calgary, Alberta, Canada;r Division of Dermatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada;s Section of Community Pediatrics, Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada;v Section of Pediatric Rheumatology, Department of Pediatrics, University of Calgary, Calgary, Alberta, CanadaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-8315-2522
ORCID Icon show all
Pages 2692-2694 | Received 04 Jan 2022, Accepted 27 Jan 2022, Published online: 21 Apr 2022
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
Click to increase image sizeClick to decrease image sizeFree first page

Disclosure statement

Dr. Devani has been an advisor, consultant, speaker, and/or investigator for AbbVie, Amgen, Arcutis, Bausch Health, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Concert, Dermavant, Dermira, Eli Lilly, Galderma, GlaxoSmithKline, Incyte, Janssen, LEO Pharma, Novartis, Pfizer, Regeneron, Sanofi Genzyme, Sun Pharma, Tribute, and UCB.

Dr. Gooderham has been an advisor, consultant, speaker, and/or investigator for AbbVie, Amgen, Akros, Arcutis, Bausch Health, Boehringer Ingelheim, Celgene, Dermavant Dermira, Eli Lilly, Galderma, GlaxoSmithKline, Janssen, Kyowa Kirin, LEO Pharma, Medimmune, Merck, Novartis, Pfizer, Regeneron, Sanofi Genzyme, UCB, and Valeant.

Dr. Hong has been an advisor, consultant, speaker, and/or investigator for AbbVie, Actelion, Akros, Amgen, Arcutis, Bausch Health, Boehringer-Ingelheim, Bristol Meyers Squibb, Celgene, Dermira, Dermavant, Eli Lilly, Galderma, GlaxoSmithKline, Incyte, Janssen, LEO Pharma, Medimmune, Merck, Novartis, Pfizer, Regeneron, Roche, Sanofi Genzyme, Sun Pharma, UCB, and Valeant.

Dr. Jain has been an advisor, consultant, speaker, and/or investigator for Abbvie, ALK-Abelló A/S, AstraZeneca, Celgene, Eli Lilly, Galderma, LEO Pharma, Medexus, Mylan, Novartis, Pfizer, and Sanofi Genzyme.

Dr. Lansang has been an advisor, consultant, speaker, and/or investigator for AbbVie, Amgen, Celgene, Eli Lilly, Janssen, Leo Pharma, Novartis, and Valeant.

Dr. Vender has been an advisor, consultant, speaker, and/or investigator for AbbVie, Actelion, Amgen, Astellas, Celgene, Dermira, Eli Lilly, Galderma, Janssen, LEO Pharma, Merck, Novartis, Pfizer, Regeneron, and Takeda.

Dr. Yeung has been an advisor, consultant, speaker, and/or investigator for AbbVie, Allergan, Amgen, Arcutis, Astellas, Bausch Health, Boehringer Ingelheim, Bristol Meyers Squibb, Celgene, Centocor, Coherus, Dermavant, Dermira, Eli Lilly, Forward, Galderma, GlaxoSmithKline, Incyte, Janssen, Kyowa Kirin, LEO Pharma, Medimmune, Merck, Novartis, Pfizer, Regeneron, Roche, Sandoz, Sanofi Genzyme, Sun Pharma, Takeda, UCB, Valeant, and Xenon.

Dr. Prajapati has been an advisor, speaker, consultant, and/or investigator for AbbVie, Actelion, Amgen, AnaptysBio, Aralez, Arcutis, Asana, Aspen, Bausch Health, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Cipher, Concert, Dermavant, Dermira, Eli Lilly, Galderma, GlaxoSmithKline, Homeocan, Incyte, Janssen, LEO Pharma, Medexus, Novartis, Pediapharm, Pfizer, Regeneron, Sanofi Genzyme, Sun Pharma, Tribute, UCB, and Valeant.

Dr. Rankin, Dr. Georgakopoulos, Ms. Sachdeva, and Dr. Mufti have no conflicts of interest to disclose.

IRB approval status

Ethical approval was granted by the Research Ethics Board at Sunnybrook Health Sciences Center (205-2018) and Women’s College Hospital (2018-0079-E).

Log in via your institution

Access through your institution

Log in to Taylor & Francis Online

Restore content access

Restore content access for purchases made as guest
Purchase options * Save for later
PDF download + Online access
  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart
* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.